Nolan Maloney

14PUBLICATIONS
8CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medicinal and biomolecular chemistry not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 28, 2020
Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: A review.

Jason J Yang, Nolan J Maloney, Kevin A Nguyen

|Sep 23, 2020
Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review.

Jason J Yang, Donald K Lei, Vignesh Ravi

|Aug 18, 2020
Alopecia areata as an immune-related adverse event of immune checkpoint inhibitors: A review.

Layal Antoury, Nolan J Maloney, Daniel Q Bach

|Apr 14, 2020
Off-Label studies on anakinra in dermatology: a review.

Kyle Tegtmeyer, Giancarlo Atassi, Jeffrey Zhao

|Feb 14, 2020
Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review.

Nolan J Maloney, Vignesh Ravi, Kyle Cheng

|Oct 05, 2019
Off-label studies on tofacitinib in dermatology: a review.

Kyle Tegtmeyer, Jeffrey Zhao, Nolan J Maloney

Pageof 3